Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia

NCT01132456 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT01132456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01132456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia
Lead sponsor
Medtronic Vascular
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2016
Enrollment
312 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, cardiovascular diseases, coronary artery disease, coronary stenosis, ischemic heart disease